The study was presented in part at the ARVO annual meeting, May 2015, Denver, Colorado, USA.
Supported in part by unrestricted grants from Research to Prevent Blindness, Inc. (New York, NY, USA) and Alcon Laboratories (Fort Worth, TX, USA) to the Department of Ophthalmology and Visual Sciences, John A. Moran Eye Center, University of Utah.
Disclosure: L. Werner, AMO (F), Alcon (F, C), Anew Optics (F), Bausch & Lomb (F), ClarVista Medical (F), CORD (F), Hoya (F), LensGen (F), Medicontur (F), Mynosys (F), Omega (F), Powervision (F, C), Zeiss (F); J.C. Stover, P; J. Schwiegerling, None; K.K. Das, Alcon (E)